Lyell Immunopharma (LYEL) EBITDA Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lyell Immunopharma | 379.11 Mn | 379.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.45 Mn |
| Dec 31, 2025 | -208.67 Mn |
| Sep 30, 2025 | 27.68 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Mar 31, 2025 | 100.16 Mn |
| Dec 31, 2024 | -162.14 Mn |
| Sep 30, 2024 | 22.46 Mn |
| Jun 30, 2024 | 168.02 Mn |
| Mar 31, 2024 | -163.38 Mn |
| Dec 31, 2023 | -20.02 Mn |
| Sep 30, 2023 | 3.25 Mn |
| Jun 30, 2023 | -13.38 Mn |
| Mar 31, 2023 | -9.73 Mn |
| Dec 31, 2022 | 239.66 Mn |
| Sep 30, 2022 | -239.65 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | -1.02 Mn |
| Dec 31, 2021 | -124,235.00 |
| Sep 30, 2021 | 60,622.00 |
| Jun 30, 2021 | -13,022.00 |
| Mar 31, 2021 | -55,981.00 |
| Dec 31, 2020 | 169,887.00 |
| Sep 30, 2020 | -16,926.00 |